UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ethical and procedural issues for applying researcher-driven multi-national paediatric clinical trials in and outside the European Union: the challenging experience of the DEEP project

BMC medical ethics, 2021-04, Vol.22 (1), p.49-49, Article 49

2021

Volltextzugriff (PDF)

Evolution of hemoglobinopathy prevention in Africa: results, problems and prospect

Mediterranean journal of hematology and infectious diseases, 2009-11, Vol.1 (1), p.e2009005-e2009005

Fattoum, Slaheddine

2009

Volltextzugriff (PDF)

A lower-cost protocol for sickle cell disease neonatal screening in Tunisia

Annals of Saudi medicine, 2012-01, Vol.32 (1), p.49-52

2012

Volltextzugriff (PDF)

Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up

Blood, 2011-07, Vol.118 (4), p.884-893

2011

Volltextzugriff (PDF)

EVOLUTION OF HEMOGLOBINOPATHY PREVENTION IN AFRICA

Mediterranean journal of hematology and infectious diseases, 2009-06, Vol.1 (1), p.e2009005-e2009005

Slaheddine Fattoum

2009

Volltextzugriff (PDF)

Point:Counterpoint: Sickle cell trait should/should not be considered asymptomatic and as a benign condition during physical activity

Journal of applied physiology (1985), 2007-12, Vol.103 (6), p.2137-2138

2007

Volltextzugriff (PDF)

EVOLUTION OF HEMOGLOBINOPATHY PREVENTION IN AFRICA

Mediterranean journal of hematology and infectious diseases, 2009-10, Vol.1 (1), p.e2009005-e2009005

Slaheddine Fattoum

2009

Volltextzugriff (PDF)

Red cell indices: differentiation between β-thalassemia trait and iron deficiency anemia and application to sickle-cell disease and sickle-cell thalassemia

Clinical chemistry and laboratory medicine, 2013-11, Vol.51 (11), p.2115-2124

2013

Volltextzugriff (PDF)

Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data

Tunisie Medicale, 2006-11, Vol.84 (11), p.687

Fattoum, Slaheddine

2006

Volltextzugriff (PDF)

Setup of a Protocol of Molecular Diagnosis of [beta]-Thalassemia Mutations in Tunisia using Denaturing High-Performance Liquid Chromatography (DHPLC)

Journal of clinical laboratory analysis, 2016-09, Vol.30 (5), p.392

2016

Volltextzugriff (PDF)

Setup of a Protocol of Molecular Diagnosis of β-Thalassemia Mutations in Tunisia using Denaturing High-Performance Liquid Chromatography (DHPLC)

Journal of clinical laboratory analysis, 2016-09, Vol.30 (5), p.392-398

2016

Volltextzugriff (PDF)

First report of cystic fibrosis mutations in Libyan cystic fibrosis patients

Annals of human biology, 2011-09, Vol.38 (5), p.561-563

2011

Volltextzugriff (PDF)

Last Word on Point:Counterpoint “Sickle cell trait should/should not be considered asymptomatic and as a benign condition during physical activity”

Journal of applied physiology (1985), 2007-12, Vol.103 (6), p.2143-2143

2007

Volltextzugriff (PDF)

Red cell indices: differentiation between β-thalassemia trait and iron deficiency anemia and application to sickle cell disease and sickle cell thalassemia

Clinical chemistry and laboratory medicine, 2013-08, Vol.51 (8), p.1595-1603

2013

Volltextzugriff (PDF)

Point: Sickle cell trait should be considered asymptomatic and as a benign condition during physical activity

Journal of applied physiology (1985), 2007-12, Vol.103 (6), p.2137-8; discussion 2141

2007

Volltextzugriff (PDF)

Contribution of β-globin cluster polymorphisms to raise fetal hemoglobin levels in normal adults

Molecular biology reports, 2012-04, Vol.39 (4), p.4619-4625

2012

Volltextzugriff (PDF)

Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia

Genetic testing and molecular biomarkers, 2009-10, Vol.13 (5), p.577-581

2009

Volltextzugriff (PDF)

Contribution of [beta]-globin cluster polymorphisms to raise fetal hemoglobin levels in normal adults

Molecular biology reports, 2012-04, Vol.39 (4), p.4619

2012

Volltextzugriff (PDF)

The epidemiology of abnormal hemoglobins in Mediterranean high-level athletes

European journal of applied physiology, 2010-04, Vol.108 (6), p.1075-1081

2010

Volltextzugriff (PDF)

Fortuitous description of hemoglobin Hope in a high-level Tunisian athlete: molecular diagnosis and origin

Annales de biologie clinique (Paris), 2012-05, Vol.70 (3), p.295-298

2012

Volltextzugriff (PDF)

Haplotypes Linked to Three Rare β-Thalassemia Mutations, Originally Reported in Tunisia

Hemoglobin, 2006-01, Vol.30 (2), p.175-181

2006

Volltextzugriff (PDF)

Detection of Two Rare β-Thalassemia Alleles Found in the Tunisian Population: Codon 47 (+A) and Codons 106/107 (+G)

Hemoglobin, 2006, Vol.30 (4), p.437-447

2006

Volltextzugriff (PDF)

Molecular Basis of β-Thalassemia in the Population of Tunisia

Hemoglobin, 2004-01, Vol.28 (3), p.177-187

2004

Volltextzugriff (PDF)

Détection fortuite de l'hémoglobine Hope chez un athlète tunisien de haut niveau: diagnostic moléculaire et origine

Annales de biologie clinique (Paris), 2012, Vol.70 (3), p.295-298

2012

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(40)

Sprache

Englisch
(36)
Französisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ethical and procedural issues for applying researcher-driven multi-national paediatric clinical trials in and outside the European Union: the challenging experience of the DEEP project

Evolution of hemoglobinopathy prevention in Africa: results, problems and prospect

A lower-cost protocol for sickle cell disease neonatal screening in Tunisia

Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia

EVOLUTION OF HEMOGLOBINOPATHY PREVENTION IN AFRICA

Point:Counterpoint: Sickle cell trait should/should not be considered asymptomatic and as a benign condition during physical activity

EVOLUTION OF HEMOGLOBINOPATHY PREVENTION IN AFRICA

Red cell indices: differentiation between β-thalassemia trait and iron deficiency anemia and application to sickle-cell disease and sickle-cell thalassemia

Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data

Setup of a Protocol of Molecular Diagnosis of [beta]-Thalassemia Mutations in Tunisia using Denaturing High-Performance Liquid Chromatography (DHPLC)

Setup of a Protocol of Molecular Diagnosis of β-Thalassemia Mutations in Tunisia using Denaturing High-Performance Liquid Chromatography (DHPLC)

First report of cystic fibrosis mutations in Libyan cystic fibrosis patients

Last Word on Point:Counterpoint “Sickle cell trait should/should not be considered asymptomatic and as a benign condition during physical activity”

Red cell indices: differentiation between β-thalassemia trait and iron deficiency anemia and application to sickle cell disease and sickle cell thalassemia

Point: Sickle cell trait should be considered asymptomatic and as a benign condition during physical activity

Contribution of β-globin cluster polymorphisms to raise fetal hemoglobin levels in normal adults

Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia

Contribution of [beta]-globin cluster polymorphisms to raise fetal hemoglobin levels in normal adults

The epidemiology of abnormal hemoglobins in Mediterranean high-level athletes

Fortuitous description of hemoglobin Hope in a high-level Tunisian athlete: molecular diagnosis and origin

Haplotypes Linked to Three Rare β-Thalassemia Mutations, Originally Reported in Tunisia

Detection of Two Rare β-Thalassemia Alleles Found in the Tunisian Population: Codon 47 (+A) and Codons 106/107 (+G)

Molecular Basis of β-Thalassemia in the Population of Tunisia

Détection fortuite de l'hémoglobine Hope chez un athlète tunisien de haut niveau: diagnostic moléculaire et origine

Suchergebnisse filtern